Cargando…

A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer

BACKGROUND: The prognosis for patients with hepatocellular cancer (HCC) undergoing transarterial therapy (TACE/TAE) is variable. METHODS: We carried out Cox regression analysis of prognostic factors using a training dataset of 114 patients treated with TACE/TAE. A simple prognostic score (PS) was de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadalayil, L., Benini, R., Pallan, L., O'Beirne, J., Marelli, L., Yu, D., Hackshaw, A., Fox, R., Johnson, P., Burroughs, A. K., Palmer, D. H., Meyer, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023407/ https://www.ncbi.nlm.nih.gov/pubmed/23857958 http://dx.doi.org/10.1093/annonc/mdt247

Ejemplares similares

A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
por: Meyer, T, et al.
Publicado: (2013)

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion
por: Waked, Imam, et al.
Publicado: (2017)

Outcomes of Transarterial Embolisation (TAE) vs. Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Lawson, Alexander, et al.
Publicado: (2023)

Transarterial embolisation of hepatocellular carcinoma with doxorubicin-eluting beads: single centre early experience
por: Nawawi, O, et al.
Publicado: (2010)

Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’
por: Huo, Teh-Ia, et al.
Publicado: (2017)

Reply to ‘Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’ ’
por: Waked, Iman, et al.
Publicado: (2017)

Associating liver partition and portal vein ligation or combined transarterial chemo-embolisation and portal vein embolisation for staged hepatectomy for HBV-related hepatocellular carcinoma
por: Gavriilidis, Paschalis, et al.
Publicado: (2023)

Treatment of hepatic metastases from medullary thyroid cancer with transarterial embolisation
por: Hughes, Peter, et al.
Publicado: (2017)

Transarterial Embolisation of a Gastroduodenal Artery Pseudoaneurysm Rupture Into the Portal Vein
por: Sarkadi, Hunor, et al.
Publicado: (2023)

Transarterial embolisation is associated with improved survival in patients with pelvic fracture: propensity score matching analyses
por: Kim, Hohyun, et al.
Publicado: (2020)

Haematological risk factors predicting clinical success in transarterial embolisation for acute gastrointestinal bleeding
por: Delf, Jonathan, et al.
Publicado: (2023)

Intercostal artery pseudoaneurysm complicating corrosive acid poisoning: Diagnosis with CT and treatment with transarterial embolisation
por: Chalapathi Rao, MV, et al.
Publicado: (2014)

Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival—prospective interventional study
por: Bessar, Ahmed A., et al.
Publicado: (2021)

Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach
por: Han, Guohong, et al.
Publicado: (2020)

Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization
por: Wang, Zhe-Xuan, et al.
Publicado: (2020)

Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach
por: Grgurevic, Ivica, et al.
Publicado: (2021)

From lending to learning: the development and extension of public libraries
por: O'Beirne, Rónán
Publicado: (2010)

Puzzles and paradoxes: fascinating excursions in recreational mathematics
por: O'Beirne, T H
Publicado: (1984)

Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort
por: Papastergiou, V, et al.
Publicado: (2014)

Safety and efficacy of transarterial embolization of hepatocellular adenomas
por: van Rosmalen, B. V., et al.
Publicado: (2019)

Reversible occlusion of the pulmonary vasculature by transarterial embolisation with degradable starch microspheres: preclinical assessment in a human isolated lung perfusion model
por: Schaarschmidt, Benedikt M., et al.
Publicado: (2022)

Neurogenic diabetes insipidus presenting in a patient with subacute liver failure: a case report
por: Shankar Hari, Manu, et al.
Publicado: (2010)

Early Experience of Trans-arterial Chemo-Embolisation for Hepatocellular Carcinoma with a Novel Radiopaque Bead
por: Reicher, John, et al.
Publicado: (2019)

Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
por: Zhao, Dongxu, et al.
Publicado: (2023)

Synchronous Hepatic Epithelioid Hemangioendothelioma and Hepatocellular Carcinoma: First Case Report in the Literature and Challenges
por: Athanasopoulos, Panagiotis G., et al.
Publicado: (2015)

Imaging of a Cilioretinal Artery Embolisation
por: Munk, Marion R., et al.
Publicado: (2014)

Uterine Artery Embolisation of Fibroids and the Phenomenon of Post-Embolisation Syndrome: A Systematic Review
por: Waldron, Michael G., et al.
Publicado: (2022)

Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study
por: Zhou, Zhong-Guo, et al.
Publicado: (2016)

Embolisation of cancer: what is the evidence?
por: Goode, J A, et al.
Publicado: (2004)

Embolised ASD device in LV
por: Raut, Monish S., et al.
Publicado: (2016)

Epidural haemorrhage during embolisation: a rare complication of intra-arterial embolisation of vertebral metastases
por: Hashim, H, et al.
Publicado: (2011)

Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
por: Kim, David Sooik, et al.
Publicado: (2021)

The combination of sarcopenia and biochemical factors can predict the survival of hepatocellular carcinoma patients receiving transarterial chemoembolization
por: Chien, Tzu-Ping, et al.
Publicado: (2022)

Direct haemodynamic effects of pulmonary arteriovenous malformation embolisation
por: Vorselaars, V. M. M., et al.
Publicado: (2014)

Applicability of scoring systems predicting outcome of transarterial chemoembolization for hepatocellular carcinoma
por: Vogeler, Marie, et al.
Publicado: (2020)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
por: Fateen, Waleed, et al.
Publicado: (2017)

Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?
por: Kotsifa, Evgenia, et al.
Publicado: (2022)

Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization
por: Lin, Po-Ting, et al.
Publicado: (2022)

Endovascular Embolisation of Visceral Artery Pseudoaneurysms
por: Khattak, Yasir Jamil, et al.
Publicado: (2014)

Comparison of conservative treatment versus transcatheter arterial embolisation for the treatment of spontaneously ruptured hepatocellular carcinoma
por: Shinmura, Kohei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9cj3nalr5rtnpcpka5f5ji41o0